封面
市場調查報告書
商品編碼
1829907

2025年全球血流動力學流量調節設備市場報告

Hemodynamic Flow Alteration Devices Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,血流動力學流量調節設備市場呈現強勁成長勢頭,市場規模從2024年的8.2億美元成長至2025年的8.8億美元,複合年成長率達7.9%。預測期內的成長歸因於人口老化、醫療成本上漲、心血管疾病及肥胖、糖尿病和高血壓等風險因素的盛行率上升,以及研發投入的增加。

預計未來幾年,血流動力學流量改變設備市場規模將強勁成長,到2029年將達到12.1億美元,複合年成長率為8.1%。預測期內的成長歸因於神經血管疾病盛行率的上升、對微創神經外科手術的需求、老年患者群體的不斷成長、血栓事件風險的上升以及可支配收入的提高。預測期內的主要趨勢包括微創手術、生物相容性材料的進步、穿戴式監測系統、人工智慧和機器學習的整合以及與心臟監測系統的整合。

血流動力學調節器是用於調節循環系統內血流的醫療設備。這類器械常用於血管外科手術和心臟治療等手術。它們可以影響血流速度、方向、阻力和其他參數,從而改善血液循環或減輕重要器官的壓力。

血流動力學調節裝置的主要類型包括栓塞保護裝置和慢性完全阻塞設備。栓塞保護裝置專門設計用於捕捉和清除在血管成形術等手術過程中可能脫落的栓塞物質,從而防止其進入重要器官並造成阻塞。這些裝置用於各種應用,包括心血管、神經系統、腎臟和呼吸系統疾病,並被多種終端使用者使用,包括醫院、診所、門診護理中心和居家照護機構。

2025年春季美國關稅大幅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要重新認證醫療設備,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供血流動力學流量調節設備市場統計數據,例如全球市場規模、各地區佔有率、競爭對手的市場佔有率、詳細的血流動力學流量調節設備細分市場、市場趨勢以及血流動力學流量調節設備行業的商機,為您提供在血流動力學流量調節設備行業取得成功所需的數據。本血流動力學流量調節設備市場研究報告透過對產業現狀和未來情勢的詳細分析,全面概述了您所需的一切。

未來五年預測成長率為8.1%,較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對英國英國和比利時等主要地區的血流改道支架和動脈瘤栓塞線圈徵收關稅直接影響美國,從而導致神經血管介入治療的延誤和腦動脈瘤治療費用的增加。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響,這種影響也將更加廣泛地顯現。

心血管疾病盛行率的上升預計將推動血流動力學流量調節劑市場的擴張。心血管疾病 (CVD) 包括影響心臟和血管的各種疾病。心血管疾病患者的增加主要是由於人口老化、不健康飲食、久坐不動的生活方式以及高血壓和糖尿病等疾病發病率上升等因素造成的。血流動力學流量調節劑對於管理心臟衰竭、高血壓和動脈阻塞等心血管疾病患者的血流至關重要。例如,根據英國心血管研究慈善機構英國心臟基金會的報告,英國約有 760 萬人患有心臟和循環系統疾病,其中包括 400 萬名男性和 360 萬名女性。預計到 2030 年這數字將增加 100 萬,到 2040 年將再增加 200 萬。因此,心血管疾病盛行率的上升是血流動力學流量調節劑市場的主要驅動力。

血流動力學流量改變設備市場的主要企業正致力於開發先進的解決方案,例如左心室輔助裝置 (LVAD),以提供更好的心臟支持、改善患者預後並應對全球日益成長的心臟衰竭發病率。 LVAD 是植入嚴重心臟衰竭患者體內的機械泵,用於輔助心臟泵血。例如,2022 年 1 月,印度政府下屬研究機構印度理工學院坎普爾分校發起了舉措。該計劃旨在開發尖端 LVAD,以滿足終末期心臟衰竭患者的需求。該設備旨在作為心臟移植的橋樑,或為不適合移植的患者提供長期解決方案。

2024年10月,美國製藥公司強生公司(Johnson & Johnson)收購了V-Wave,具體金額未揭露。此次收購旨在透過將V-Wave突破性的文圖拉心房分流術納入其醫療科技產品組合,鞏固強生在心血管領域的地位。 V-Wave總部位於美國,專注於開發血流動力學流量調節裝置。

血流動力學流量調節設備市場包括流量轉向器、血管支架、流量調節器、監測工具和診斷工具的銷售。該市場的價值是指“出廠價”,即產品製造商或創造者銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的價值。該市場的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、貿易戰和關稅,以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球血流動力學流量改變設備:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 最終用途產業分析
  • 全球血流動力學流量調節裝置市場:成長率分析
  • 全球血流動力學流量調節設備市場表現:規模與成長,2019-2024
  • 全球血流動力學流量調節設備市場預測:規模與成長,2024-2029年,2034年
  • 全球血流動力學流量調節設備:總目標市場(TAM)

第6章 市場細分

  • 全球血流動力學流量調節設備市場類型、效能及預測(2019-2024、2024-2029、2034)
  • 栓塞保護裝置
  • 慢性完全封堵器
  • 全球血流動力學流量調節設備市場應用、效能及預測(2019-2024、2024-2029、2034)
  • 心血管疾病
  • 神經系統疾病
  • 腎臟疾病
  • 呼吸系統疾病
  • 全球血流動力學流量調節設備市場(按最終用戶、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 門診治療中心
  • 居家照護環境
  • 其他最終用戶
  • 全球血流動力學流量調節裝置市場:按栓塞保護裝置細分(按類型)、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 遠端栓塞保護裝置
  • 近端栓塞保護裝置
  • 基於過濾器的栓塞防護裝置
  • 基於球囊的栓塞保護裝置
  • 網狀或籠狀栓塞防護裝置
  • 全球血流動力學流量調節裝置市場:慢性完全閉塞裝置的細分(按類型)、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • CTO交叉導管導引線
  • CTO球囊導管
  • CTO微導管
  • CTO 再入裝置
  • CTO支援導管

第7章 區域和國家分析

  • 全球血流動力學流量調節設備市場:按地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球血流動力學流量調節設備市場:依國家、績效及預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章:西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 血流動力學流量調節裝置市場:競爭格局
  • 血流動力學流量調節裝置市場:公司簡介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • Stryker Corporation
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • WL Gore & Associates Inc.
  • ZOLL Medical Corporation
  • Getinge AB
  • Lepu Medical Technology(Beijing)Co. Ltd.
  • Abiomed Inc.
  • LivaNova PLC
  • Cordis US Corp.
  • Silk Road Medical Inc.
  • Berlin Heart GmbH
  • CorWave SA
  • Jarvik Heart Inc.
  • CARMAT SA

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章:高潛力市場國家、細分市場與策略

  • 2029 年血流動力學流量調節設備市場:提供新機會的國家
  • 2029 年血流動力學流量調節設備市場:細分市場帶來新機會
  • 2029 年血流動力學流量調節設備市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33761u

Hemodynamic flow alteration devices are medical instruments designed to modify the dynamics of blood flow within the circulatory system. These devices are often utilized in procedures such as vascular surgery or heart condition treatments. They can influence factors such as the speed, direction, or resistance of blood flow to enhance circulation or reduce strain on vital organs.

The primary types of hemodynamic flow alteration devices include embolic protection devices and chronic total occlusion devices. An embolic protection device is specifically designed to capture and remove embolic material that may become dislodged during procedures such as angioplasty. This prevents the material from traveling to vital organs and causing blockages. These devices are used in various applications, including cardiovascular diseases, neurological disorders, renal conditions, and respiratory disorders, and are employed by several end users, including hospitals, clinics, ambulatory care centers, home care settings, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hemodynamic flow alteration devices market research report is one of a series of new reports from The Business Research Company that provides hemodynamic flow alteration devices market statistics, including the hemodynamic flow alteration devices industry global market size, regional shares, competitors with the hemodynamic flow alteration devices market share, detailed hemodynamic flow alteration devices market segments, market trends, and opportunities, and any further data you may need to thrive in the hemodynamic flow alteration devices industry. This hemodynamic flow alteration devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hemodynamic flow alteration devices market size has grown strongly in recent years. It will grow from $0.82 billion in 2024 to $0.88 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to growth in the aging population, rise in healthcare expenditure, increase in the prevalence of cardiovascular diseases, rise in risk factors such as obesity, diabetes, and hypertension, and increase in R&D.

The hemodynamic flow alteration devices market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to the increasing prevalence of neurovascular diseases, demand for minimally invasive neurosurgery, increasing geriatric patients, rising risk of thrombotic events, and rising disposable income. Major trends in the forecast period include minimally invasive procedures, advancements in biocompatible materials, wearable monitoring systems, artificial intelligence and machine learning integration, and integration with cardiac monitoring systems.

The forecast of 8.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on flow-diverting stents and aneurysm embolization coils, sourced from key regions such as the UK and Belgium, which could lead to delayed neurovascular interventions and higher costs for treating cerebral aneurysms.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the hemodynamic flow alteration devices market. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The rise in CVD cases is primarily attributed to factors such as aging populations, unhealthy diets, sedentary lifestyles, and increasing rates of conditions such as hypertension and diabetes. Hemodynamic flow alteration devices are crucial for managing blood flow in patients with cardiovascular conditions such as heart failure, hypertension, and arterial blockages. For example, a report by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are living with heart and circulatory diseases, with 4 million men and 3.6 million women affected. By 2030, this number is projected to increase by 1 million, and by 2040, it could rise by an additional 2 million. Thus, the growing prevalence of cardiovascular diseases is a key driver for the hemodynamic flow alteration devices market.

Leading companies in the hemodynamic flow alteration devices market are focusing on the development of advanced solutions such as left ventricular assist devices (LVADs) to provide better cardiac support, improve patient outcomes, and tackle the rising incidence of heart failure worldwide. An LVAD is a mechanical pump implanted in patients with severe heart failure to assist the heart in pumping blood. For example, in January 2022, the Indian Institute of Technology-Kanpur, a government research institute based in India, launched an initiative called Hridyantra. This project aims to develop a cutting-edge LVAD to meet the needs of patients with end-stage heart failure. The device is intended to either serve as a bridge to a heart transplant or provide a long-term solution for those who are not candidates for a transplant.

In October 2024, Johnson & Johnson, a pharmaceutical company based in the US, acquired V-Wave Inc. for an undisclosed sum. This acquisition is intended to bolster Johnson & Johnson's position in the cardiovascular disease sector by adding V-Wave's groundbreaking Ventura interatrial shunt to its MedTech portfolio. V-Wave Inc., a US-based company, specializes in the development of hemodynamic flow alteration devices.

Major players in the hemodynamic flow alteration devices market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Getinge AB, Lepu Medical Technology (Beijing) Co. Ltd., Abiomed Inc., LivaNova PLC, Cordis US Corp., Silk Road Medical Inc., Berlin Heart GmbH, CorWave SA, Jarvik Heart Inc., and CARMAT SA.

North America was the largest region in the hemodynamic flow alteration devices market in 2024. The regions covered in hemodynamic flow alteration devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hemodynamic flow alteration devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemodynamic flow alteration devices market consists of sales of flow diverters, vascular stents, blood flow regulators, and monitoring tools. Values in and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemodynamic Flow Alteration Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemodynamic flow alteration devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemodynamic flow alteration devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemodynamic flow alteration devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Embolic Protection Device; Chronic Total Occlusion Device
  • 2) By Application: Cardiovascular Diseases; Neurological Disorders; Renal Disorders; Respiratory Disorders
  • 3) By End User: Hospitals; Clinics; Ambulatory Care Centre; Home Care Setting; Other End Users
  • Subsegments:
  • 1) By Embolic Protection Device: Distal Embolic Protection Devices; Proximal Embolic Protection Devices; Filter-Based Embolic Protection Devices; Balloon-Based Embolic Protection Devices; Mesh Or Cage-Based Embolic Protection Devices
  • 2) By Chronic Total Occlusion Device: Crossing Guidewires For CTO; CTO Balloon Catheters; CTO Microcatheters; Re-Entry Devices For CTO; CTO Support Catheters
  • Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthcare GmbH; Becton Dickinson and Company; Stryker Corporation; Boston Scientific Corporation; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; ZOLL Medical Corporation; Getinge AB; Lepu Medical Technology (Beijing) Co. Ltd.; Abiomed Inc.; LivaNova PLC; Cordis US Corp.; Silk Road Medical Inc.; Berlin Heart GmbH; CorWave SA; Jarvik Heart Inc.; CARMAT SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemodynamic Flow Alteration Devices Market Characteristics

3. Hemodynamic Flow Alteration Devices Market Trends And Strategies

4. Hemodynamic Flow Alteration Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemodynamic Flow Alteration Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemodynamic Flow Alteration Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemodynamic Flow Alteration Devices Market Growth Rate Analysis
  • 5.4. Global Hemodynamic Flow Alteration Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemodynamic Flow Alteration Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemodynamic Flow Alteration Devices Total Addressable Market (TAM)

6. Hemodynamic Flow Alteration Devices Market Segmentation

  • 6.1. Global Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolic Protection Device
  • Chronic Total Occlusion Device
  • 6.2. Global Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Neurological Disorders
  • Renal Disorders
  • Respiratory Disorders
  • 6.3. Global Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Care Centre
  • Home Care Setting
  • Other End Users
  • 6.4. Global Hemodynamic Flow Alteration Devices Market, Sub-Segmentation Of Embolic Protection Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Distal Embolic Protection Devices
  • Proximal Embolic Protection Devices
  • Filter-Based Embolic Protection Devices
  • Balloon-Based Embolic Protection Devices
  • Mesh Or Cage-Based Embolic Protection Devices
  • 6.5. Global Hemodynamic Flow Alteration Devices Market, Sub-Segmentation Of Chronic Total Occlusion Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crossing Guidewires For CTO
  • CTO Balloon Catheters
  • CTO Microcatheters
  • Re-Entry Devices For CTO
  • CTO Support Catheters

7. Hemodynamic Flow Alteration Devices Market Regional And Country Analysis

  • 7.1. Global Hemodynamic Flow Alteration Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemodynamic Flow Alteration Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemodynamic Flow Alteration Devices Market

  • 8.1. Asia-Pacific Hemodynamic Flow Alteration Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemodynamic Flow Alteration Devices Market

  • 9.1. China Hemodynamic Flow Alteration Devices Market Overview
  • 9.2. China Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemodynamic Flow Alteration Devices Market

  • 10.1. India Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemodynamic Flow Alteration Devices Market

  • 11.1. Japan Hemodynamic Flow Alteration Devices Market Overview
  • 11.2. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemodynamic Flow Alteration Devices Market

  • 12.1. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemodynamic Flow Alteration Devices Market

  • 13.1. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemodynamic Flow Alteration Devices Market

  • 14.1. South Korea Hemodynamic Flow Alteration Devices Market Overview
  • 14.2. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemodynamic Flow Alteration Devices Market

  • 15.1. Western Europe Hemodynamic Flow Alteration Devices Market Overview
  • 15.2. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemodynamic Flow Alteration Devices Market

  • 16.1. UK Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemodynamic Flow Alteration Devices Market

  • 17.1. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemodynamic Flow Alteration Devices Market

  • 18.1. France Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemodynamic Flow Alteration Devices Market

  • 19.1. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemodynamic Flow Alteration Devices Market

  • 20.1. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemodynamic Flow Alteration Devices Market

  • 21.1. Eastern Europe Hemodynamic Flow Alteration Devices Market Overview
  • 21.2. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemodynamic Flow Alteration Devices Market

  • 22.1. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemodynamic Flow Alteration Devices Market

  • 23.1. North America Hemodynamic Flow Alteration Devices Market Overview
  • 23.2. North America Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemodynamic Flow Alteration Devices Market

  • 24.1. USA Hemodynamic Flow Alteration Devices Market Overview
  • 24.2. USA Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemodynamic Flow Alteration Devices Market

  • 25.1. Canada Hemodynamic Flow Alteration Devices Market Overview
  • 25.2. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemodynamic Flow Alteration Devices Market

  • 26.1. South America Hemodynamic Flow Alteration Devices Market Overview
  • 26.2. South America Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemodynamic Flow Alteration Devices Market

  • 27.1. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemodynamic Flow Alteration Devices Market

  • 28.1. Middle East Hemodynamic Flow Alteration Devices Market Overview
  • 28.2. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemodynamic Flow Alteration Devices Market

  • 29.1. Africa Hemodynamic Flow Alteration Devices Market Overview
  • 29.2. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemodynamic Flow Alteration Devices Market Competitive Landscape And Company Profiles

  • 30.1. Hemodynamic Flow Alteration Devices Market Competitive Landscape
  • 30.2. Hemodynamic Flow Alteration Devices Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Hemodynamic Flow Alteration Devices Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. Boston Scientific Corporation
  • 31.3. Edwards Lifesciences Corporation
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. ZOLL Medical Corporation
  • 31.6. Getinge AB
  • 31.7. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.8. Abiomed Inc.
  • 31.9. LivaNova PLC
  • 31.10. Cordis US Corp.
  • 31.11. Silk Road Medical Inc.
  • 31.12. Berlin Heart GmbH
  • 31.13. CorWave SA
  • 31.14. Jarvik Heart Inc.
  • 31.15. CARMAT SA

32. Global Hemodynamic Flow Alteration Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemodynamic Flow Alteration Devices Market

34. Recent Developments In The Hemodynamic Flow Alteration Devices Market

35. Hemodynamic Flow Alteration Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Hemodynamic Flow Alteration Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemodynamic Flow Alteration Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemodynamic Flow Alteration Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer